Loading clinical trials...
Loading clinical trials...
Docosahexaenoic acid (DHA) and arachidonic acid (AA) have a critical effect on the health and neuronal development of the fetus and newborn. Their deficiency has been associated with increased neonata...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Hospital Universitari Vall d'Hebron Research Institute
NCT07216664 · Infant, Premature, Diseases
NCT06335524 · Child Development, Infant Development, and more
NCT06878742 · Infant, Premature, Diseases, Circulatory and Respiratory Physiological Phenomena
NCT05030337 · Infant, Premature, Diseases, Airway Morbidity, and more
NCT05451264 · Infant, Premature, Diseases
Hospital Materno Infantil Vall d'Hebron
Barcelona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions